Friday 6 November 2026 Export PACB’s income statement to Excel — free account

Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $160.0 million, up 3.89% from fiscal 2024.

Revenue: +5.52%
EPS: +7.69%
Free cash flow: −102.0%
Total debt: −0.29%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

2.27 0.16 −6.58%

Follow PACB

Alert me

Market cap: $755.3M
P/E: 0.0×
Fwd P/E: −5.9×
Dividend yield: —
F-score: 3/9
Altman Z: −6.04
Beneish M: −5.14
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	1,037.83%	(929.31%)	(273.55%)	(213.45%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	4	4	5	3
ROA Full definition →	(17.22%)	(16.66%)	(15.65%)	(53.45%)
ROIC Full definition →	0.00%	(22.22%)	0.00%	(93.25%)
Return on Tangible Assets Full definition →	(48.51%)	(44.27%)	(39.14%)	(167.41%)
Average Days of Receivables Full definition →	86.67	71.28	66.94	80.86
Free Cash Flow per Share Full definition →	(0.44)	(0.26)	(0.23)	(0.40)
Free Cash Flow Full definition →	(136.95)	(80.48)	(71.21)	(118.92)
Capital Expenditures Full definition →	—	37.57	40.63	(7.71)
Other line items
Cash ROIC Full definition →	(99.19%)	(9.49%)	(25.58%)	(12.78%)
Accounts Receivable Turnover Full definition →	4.68	5.03	5.25	5.08
Accounts Payable Turnover Full definition →	7.76	5.91	7.24	6.11
Inventory Turnover Full definition →	1.87	1.76	1.91	2.11
Average Days of Payables Full definition →	37.64	69.25	49.65	66.37
Days of Inventory on Hand Full definition →	207.80	220.04	186.16	157.49
Tax Rate Full definition →	0.01	0.01	0.01	0.00
Research and Development Expense of Revenue Full definition →	53.12%	55.47%	54.90%	60.81%
Selling, General and Administrative Expense of Revenue Full definition →	79.32%	81.43%	82.78%	88.43%
Share Based Compensation of Revenue Full definition →	19.73%	21.53%	23.07%	26.04%
Interest Coverage Full definition →	(17.15)	(18.15)	(19.16)	(79.65)
Operating CF/Net income Full definition →	1.04	0.90	0.87	0.20
Depreciation/Fixed assets Full definition →	0.00	0.58	0.61	16.44
Capex/Depreciation Full definition →	—	2.39	2.76	(0.02)
Revenue per Share Full definition →	0.52	0.51	0.52	0.53
Operating CF per Share Full definition →	(0.44)	(0.38)	(0.37)	(0.37)
Capex per Share Full definition →	0.00	0.12	0.13	(0.03)
Capex to Sales Full definition →	0.00	(0.24)	(0.25)	0.05

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly